Alarming Surge in Sleeping Pill Prescriptions for Australian Children
A significant and concerning trend is emerging within Australia’s healthcare system, with an alarming number of prescriptions for sleeping aids being issued to children and adolescents. Recent figures reveal a dramatic increase in the reliance on medication to help young people achieve a night’s sleep, prompting calls for urgent investigation into the underlying causes and potential long-term consequences.
In a single year, over a million prescriptions for sleeping drugs have been dispensed to individuals under the age of 18. This unprecedented figure signifies a substantial rise, with more than a quarter of a million young Australians now receiving such medication. The data points to a growing struggle for many children to navigate the night without chemical assistance.
Key Statistics and Demographics
The latest available data paints a stark picture:
- Total Prescriptions: A staggering 1,060,009 prescriptions for sleeping aids were issued to under-18s in England in 2024. While this specific data is from the UK, similar trends are being observed and are a cause for concern for Australian health professionals.
- Individuals Affected: For the first time, the number of individuals under 18 receiving these medications has surpassed 250,000.
- Age Distribution: Worryingly, 12-year-olds represent the most commonly prescribed age group for sleeping pills.
- Primary School Children: A significant proportion, totalling 119,000 prescriptions, were issued to children still attending primary school.
Escalating Trend
The increase in these prescriptions has been steep and rapid. Since 2020, the number of children receiving sleeping drugs has climbed by over 100,000, while the total number of prescriptions has surged by a remarkable 400,000. This translates to approximately 20,000 prescriptions being issued to children every week by medical practitioners.

Medical Guidance and Expert Concerns
Official medical guidance stipulates that medications designed to address sleep problems, often referred to as hypnotics (which can include sedating antihistamines and melatonin treatments), should be reserved for under-18s only for the short-term management of specific conditions. These are typically limited to issues such as night terrors or sleepwalking.
However, separate reports indicate a concurrent rise in young people self-reporting sleep difficulties. Experts are increasingly linking these issues to a complex interplay of factors, including rising levels of anxiety, mounting mental health pressures, and the pervasive influence of increased screen time.
Dr Susie Davies, a General Practitioner and the founder of PAPAYA (Parents Against Phone Addiction in Young Adolescents), has voiced her deep concern over these statistics. She stated that the figures “reflect an alarming rise” in insomnia among children. Dr Davies emphasised the critical need to “examine the potential drivers and strongly consider the likely role that screen use is playing in disrupting young people’s sleep.” She further commented, “It is increasingly difficult to ignore the contribution of night-time screen use to the growing prevalence of sleep disorders among young people.”

Vicki Beevers, the chief executive of The Sleep Charity, echoed these sentiments, describing the data as “deeply concerning.” She elaborated, “Medication can have a place in very specific circumstances and under specialist guidance. However, clinical guidance is clear that hypnotics should not routinely be used for children.”
Ms Beevers highlighted the fundamental nature of sleep, stating, “Sleep is a behavioural and biological process, and in many cases children benefit most from consistent routines, supportive bedtime strategies, managing light and screen exposure and addressing underlying emotional wellbeing.”
She concluded with a call for greater support and resources, suggesting, “The rise in prescriptions suggests we need greater investment in early intervention, parent education and accessible behavioural sleep support, so families can get help before difficulties escalate to the point where medication feels like the only option.”
The escalating reliance on pharmaceutical solutions for childhood sleep disturbances demands a comprehensive and proactive approach from healthcare providers, parents, and policymakers alike. Addressing the root causes, from mental health support to digital wellbeing, is paramount to ensuring the healthy development and long-term wellbeing of Australia’s youth.





